MainReads
← Details
Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study.
Sho T, Suda G, Abe T, Ninomiya M, Endo K, Fujiwara Y, Numao H, Igarashi G, Tsuruoka M, Iino C, Yoshida K, Sato S, Nakai M, Ohara M, Kitagataya T, Kawagishi N, Katsumi T, Maki K, Sato W, Minami S, Abe K, Fujita M, Yamamoto Y, Baba M, Meguro T, Oikawa T, Tanabe N, Ueno Y, Sakamoto N, Kuroda H, for NORTH Japan HCC study group
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.